He worked for global pharmaceutical companies such as Eli Lilly and Johnson & Johnson for about 20 years in new drug development in the fields of oncology, endocrinology, and central nervous system. After that, he joined a general consulting firm where he assisted pharmaceutical companies in R&D strategy, digital health, R&D organizational reform, and data utilization.
He joined Nanotis as an individual with both practical R&D and consulting perspectives.
Tokyo Institute of Technology (Master of Science)
Bond University (MBA)